Saturday, July 11, 2026

Drug profile · INN

lamivudine + zidovudine

lamivudine + zidovudine (COMBIVIR) is an FDA-listed pharmaceutical active ingredient. Associated with ViiV Healthcare Pty Ltd.

TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — lamivudine + zidovudine

Quick answer

lamivudine + zidovudine (COMBIVIR) is an FDA-listed pharmaceutical active ingredient. Associated with ViiV Healthcare Pty Ltd.

Key facts

INN lamivudine + zidovudine
Brand COMBIVIR

Approval history

Authority Status Date
TGA approved

Frequently asked questions

What is lamivudine + zidovudine?

lamivudine + zidovudine (COMBIVIR) is an FDA-listed pharmaceutical active ingredient. Associated with ViiV Healthcare Pty Ltd.

What is the brand name for lamivudine + zidovudine?

COMBIVIR is a marketed brand name for lamivudine + zidovudine. Check FDA Drugs@FDA for the current US label holder and prescribing information.